The global Vitreous Tamponades Market is estimated to be valued at US$ 83.89 Mn in 2023 and is expected to exhibit a CAGR of 2.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Vitreous tamponades refer to substances that are injected into the eye during retinal detachment surgery to help hold the retina in place. They serve the purpose of tamponading any retinal breaks or tears until the healing process is complete. Common vitreous tamponades used include silicone oil, perfluoropropane (C3F8) gas and sulfur hexafluoride (SF6) gas. These substances help maintain pressure inside the eye and prevent aqueous humor from seeping behind the retina. Vitreous tamponade procedures have greatly improved retinal reattachment success rates after retinal detachment surgeries. Their widespread adoption by retinal surgeons globally is expected to drive the overall vitreous tamponades market growth over the forecast period.
Market key trends:
One of the key trends in the vitreous tamponades market is the rising preference for silicone oil as a tamponade agent. Silicone oil is increasingly becoming the tamponade of choice due to its long-term intraocular retention capabilities. It allows longer post-operative positioning and retains its position better in the eye as compared to gases. Moreover, silicone oils cause fewer side effects and produce more predictable surface tension tendencies as compared to gases. Their non-diffusible and non-metabolizable properties provide surgeons greater flexibility with the timing of removal surgery. All these advantages have led to silicone oils dominating the vitreous tamponades market in revenue terms. Their uptake is expected to grow further over the coming years.
Threat of new entrants: Low capital requirements and established global distribution networks lower barriers to entry in the vitreous tamponades market. However, highly regulated approval process for new products protect existing players.
Bargaining power of buyers: Large group purchasing organizations and hospitals create pressure on prices. However, specialized nature of products limits impact on pricing.
Bargaining power of suppliers: Established players hold strong position and have long-term relationships with key raw material providers and manufacturers, limiting supplier power.
Threat of new substitutes: Limited threat as vitreous tamponades have few substitutes for short-term vitreous substitution in eyes. Innovation is main strategy to ward off potential substitutes.
Competitive rivalry: Presence of large multinational corporations increases competition. Differentiation strategies focus on novel delivery systems and tailored products.
The global vitreous tamponades market is expected to witness high growth, exhibiting CAGR of 2.5% over the forecast period, due to increasing number of retinal detachment surgeries. Growing geriatric population is leading to higher incidence of eye disorders necessitating vitreous surgeries.
Regionally, North America holds the largest share in the global vitreous tamponades market due to approvals of innovative products and expanding healthcare infrastructure. However, Asia Pacific is expected emerge as the fastest growing market owing to rising medical tourism, rapid economic growth and growing focus of key players.
Key players operating in the vitreous tamponades market are Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH. Innovation is the key strategy adopted by major players with new product launches focusing on advanced delivery systems and tailored tamponade agents.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it